We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Scansource
SCSC
$1.12B
| $289K | 0.03% |
+9,498
| New | +$295K |
|
1052
Colgate-Palmolive
CL
$74.4B
| $288K | 0.03% |
+3,838
| New | +$285K |
|
1053
Bassett Furniture
BSET
$176M
| $287K | 0.03% |
16,130
-33,086
| -67% | -$614K |
|
1054
iShares Global Tech ETF
IXN
$9.26B
| $287K | 0.03% |
+5,277
| New | +$263K |
|
1055
MPLX
MPLX
$59.7B
| $287K | 0.03% |
+8,344
| New | +$287K |
|
1056
Vericel Corp
VCEL
$2.31B
| $286K | 0.03% |
+9,754
| New | +$283K |
|
|
PLYM
1057
DELISTED
Plymouth Industrial REIT
PLYM
| $285K | 0.03% |
13,567
-20,541
| -60% | -$433K |
|
1058
Accenture
ACN
$108B
| $284K | 0.03% |
+994
| New | +$271K |
|
1059
MongoDB
MDB
$32.1B
| $284K | 0.03% |
1,218
-4,884
| -80% | -$1.02M |
|
1060
MacroGenics
MGNX
$257M
| $284K | 0.03% |
39,555
-18,049
| -31% | -$109K |
|
1061
Warby Parker
WRBY
$3.27B
| $284K | 0.03% |
26,797
-84,447
| -76% | -$1.16M |
|
1062
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $283K | 0.03% |
+1,825
| New | +$287K |
|
1063
Lumen
LUMN
$6.44B
| $283K | 0.03% |
106,627
+80,456
| +307% | +$325K |
|
|
AMK
1064
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $283K | 0.03% |
+8,998
| New | +$252K |
|
1065
Ambarella
AMBA
$3.81B
| $282K | 0.03% |
+3,640
| New | +$312K |
|
1066
PLAYSTUDIOS Inc
MYPS
$90.1M
| $282K | 0.03% |
+76,499
| New | +$310K |
|
1067
1st Source
SRCE
$2.12B
| $282K | 0.03% |
+6,529
| New | +$319K |
|
1068
Pennant Group
PNTG
$1.36B
| $281K | 0.03% |
19,650
-2,337
| -11% | -$29.3K |
|
1069
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.98B
| $280K | 0.03% |
+15,266
| New | +$282K |
|
|
SHYF
1070
DELISTED
The Shyft Group
SHYF
| $280K | 0.03% |
+12,297
| New | +$345K |
|
1071
UNIFI
UFI
$134M
| $280K | 0.03% |
+34,232
| New | +$305K |
|
|
NIU
1072
Niu Technologies
NIU
$193M
| $278K | 0.03% |
+67,129
| New | +$311K |
|
1073
Blue Owl Capital
OWL
$18.5B
| $278K | 0.03% |
25,100
-19,781
| -44% | -$237K |
|
1074
SLB Ltd
SLB
$75B
| $278K | 0.03% |
+5,670
| New | +$301K |
|
1075
Buckle
BKE
$2.37B
| $277K | 0.03% |
+7,766
| New | +$318K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.